WDR4 and neoplasm: In human beings, methyltransferase-like 1 (METTL1) and the WD repeat domain 4 (WDR4) are the most well-studied regulators of m7G, and have been reported to participate in tumor progression by regulating tumor immunity, metabolic reprogramming, and drug resistance [9,10,11,12,13].